Diagnostic testing


Also found in: Wikipedia.

Diagnostic testing

Testing performed to determine if someone is affected with a particular disease.
References in periodicals archive ?
com adds new report on "Global Bone and Mineral Diagnostic Testing Market 2015-2019" of 76 pages with tables and figures to its research store.
They conducted separate analyses for screening of asymptomatic women and diagnostic testing of women with symptoms for which federal guidelines recommend STD testing (vaginal or urinary symptoms, abnormal vaginal bleeding, and abdominal or pelvic pain).
New market research report "Innovative Proteins C and S Diagnostic Testing Technologies and Emerging Markets" worked out by Venture Planning Group (VPG) presents a detailed analysis of the proteins C and S testing market in the US, Europe (France, Germany, Italy, Spain, the UK) and Japan, including clinical significance and current laboratory practice, as well as 5- and 10-year test volume forecasts by country and market segment.
Breast cancer companion diagnostic testing is expected to increase in Brazil mainlyt as a result of increasing incidence of the diseasde, with only a modest increase in access to testing amongst breast cancer patients.
New market research report "The UK Diagnostic Testing Market: Forecasts by Market Segment And Supplier Shares by Test" worked out by Venture Planning Group provides a comprehensive overview of the diagnostic testing market in the UK, including sales and market shares of major reagent and instrument suppliers, as well as test volume and sales forecasts for the key market segments - clinical chemistry and immunodiagnostics,infectious disease testing, cancer diagnostics, molecular diagnostics, hematology and flow cytometry,coagulation testing, blood banking.
LONDON -- Women's Health Diagnostic Testing Market Report.
Quidel is devoted to promoting excellence in diagnostic testing," said Caren Mason, president and CEO of Quidel.
The major feature of the companion diagnostic testing market is the current domination of tests for mutations important in the prognosis and diagnosis of non-small cell lung cancer (NSCLC), with the two market leaders being Roche and Qiagen.
He is recognized as a leader in the development of innovative scientific breakthroughs in diagnostic testing.
The market growth for companion diagnostic testing in the US and EU is heavily dependent on the acceptance into diagnostic guidelines and the stabilisation of test reimbursement.
The market for immunoprotein diagnostic testing has been segmented according to immunoprotein types which include immunoglobulins, complement system proteins, C-reactive protein (CRP), haptoglobin, prealbumin and free light chains (FLC) of immunoglobulins.

Full browser ?